argenx SE (ARGX)

argenx to Report Third Quarter 2026 Financial Results and Business Update on October 22, 2026

ARGX Investors with $100,000 in Losses Have Opportunity to Join argenx SE Fraud Investigation with SBS Law

argenx Meets Primary Endpoint in Phase II Celiac Disease Study

ARGX Stock Down on Stopping Late-Stage Autoimmune Disease Study

argenx: The Sjögren's Selloff Looks Overdone

argenx Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into argenx (ARGX)

HALO Wins Court Order Blocking Merck's Keytruda SC in Europe

argenx shares drop after trial of Vyvgart in Sjögren's disease is halted

Argenx Halts Phase 3 Study in Rare Disease Following Futility Analysis

Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble

Argenx Shares Plunge After Autoimmune-Disease Trial Halt

argenx Announces Positive Topline Results from Phase 2 Study of FB102 in Celiac Disease

argenx Provides Update on Phase 3 UNITY Study of Efgartigimod SC in Sjögren's Disease

Integrated Wealth Concepts LLC Sells 725 Shares of argenex SE $ARGX

BMY or ARGX: Which Is the Better Value Stock Right Now?

10 Wall Street Analysts Think Argenx Stock Is Headed to At Least $1,200 -- Is the Stock a Buy Now?

Ginkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium

argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline

Here's Exactly Why Wall Street Thinks Argenx Stock Could Soar 23% Over the Next 12 Months